ICD-10 Coding for Giant Cell Arteritis(H53.9U, M31.5, M31.5B)
Explore detailed ICD-10 coding guidelines for giant cell arteritis, including documentation requirements and common coding pitfalls.
Complete code families applicable to Giant Cell Arteritis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| M31.6 | Other giant cell arteritis | Use when giant cell arteritis is diagnosed without polymyalgia rheumatica. |
|
| M31.5 | Giant cell arteritis with polymyalgia rheumatica | Use when both giant cell arteritis and polymyalgia rheumatica are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutGiant Cell Arteritis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Giant Cell Arteritis.
Omitting biopsy results in documentation
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation
Ensure biopsy results are included in the patient's record., Verify documentation completeness before coding.
Coding M31.5 without PMR documentation
Impact
Reimbursement: Incorrect coding may lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure PMR symptoms are documented before using M31.5.
Documentation Completeness
Impact
Incomplete documentation of symptoms and lab results.
Mitigation
Implement thorough documentation practices and regular audits.